UBS Group’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,621
Closed -$9.35K 9262
2024
Q4
$9.35K Buy
+10,621
New +$9.35K ﹤0.01% 7126
2024
Q2
Sell
-5,178
Closed -$10.6K 8775
2024
Q1
$10.6K Buy
5,178
+5,175
+172,500% +$10.6K ﹤0.01% 6050
2023
Q4
$7 Sell
3
-25
-89% -$58 ﹤0.01% 7927
2023
Q3
$104 Buy
+28
New +$104 ﹤0.01% 7728
2023
Q2
Sell
-2,418
Closed -$11.4K 8421
2023
Q1
$11.4K Buy
2,418
+2,324
+2,472% +$10.9K ﹤0.01% 6418
2022
Q4
$466 Sell
94
-1,800
-95% -$8.92K ﹤0.01% 8972
2022
Q3
$10K Buy
+1,894
New +$10K ﹤0.01% 7355
2022
Q2
Sell
-140
Closed -$1K 9747
2022
Q1
$1K Sell
140
-1,146
-89% -$8.19K ﹤0.01% 8872
2021
Q4
$9K Buy
1,286
+1,165
+963% +$8.15K ﹤0.01% 7803
2021
Q3
$1K Sell
121
-516
-81% -$4.26K ﹤0.01% 8089
2021
Q2
$9K Buy
637
+526
+474% +$7.43K ﹤0.01% 7059
2021
Q1
$2K Sell
111
-146
-57% -$2.63K ﹤0.01% 7602
2020
Q4
$5K Buy
+257
New +$5K ﹤0.01% 6817
2020
Q2
Sell
-3,029
Closed -$17K 7316
2020
Q1
$17K Buy
3,029
+2,200
+265% +$12.3K ﹤0.01% 5690
2019
Q4
$4K Buy
+829
New +$4K ﹤0.01% 6604
2019
Q3
Sell
-82
Closed -$1K 7159
2019
Q2
$1K Buy
+82
New +$1K ﹤0.01% 6858
2018
Q4
Sell
-113
Closed -$2K 7220
2018
Q3
$2K Buy
+113
New +$2K ﹤0.01% 6823
2018
Q2
Sell
-229
Closed -$6K 7154
2018
Q1
$6K Buy
229
+175
+324% +$4.59K ﹤0.01% 6270
2017
Q4
$1K Buy
+54
New +$1K ﹤0.01% 6747
2017
Q2
Sell
-427
Closed -$13K 6860
2017
Q1
$13K Buy
427
+273
+177% +$8.31K ﹤0.01% 5539
2016
Q4
$5K Buy
+154
New +$5K ﹤0.01% 6277
2016
Q3
Sell
-122
Closed -$7K 6851
2016
Q2
$7K Sell
122
-342
-74% -$19.6K ﹤0.01% 6090
2016
Q1
$28K Buy
464
+404
+673% +$24.4K ﹤0.01% 5129
2015
Q4
$4K Sell
60
-273
-82% -$18.2K ﹤0.01% 6399
2015
Q3
$19K Buy
333
+193
+138% +$11K ﹤0.01% 5490
2015
Q2
$13K Sell
140
-392
-74% -$36.4K ﹤0.01% 5822
2015
Q1
$51K Sell
532
-188
-26% -$18K ﹤0.01% 4637
2014
Q4
$63K Buy
+720
New +$63K ﹤0.01% 4543